Biogen
Budget
€300 — €0
EP Access
3
accredited persons
Staff
4
0.8 FTE
EU Grants
None
Mission & Goals
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
EU Legislative Interests
European Pharmaceutical Strategy; EU’s Intellectual Property framework; Biotech Act; Lifesciences Strategy; Orphan Medicinal Products Regulation; EU Relative Efficacy Assessment and Health Technology Assessment; Patient access to innovation; Competition in the Pharmaceutical Sector; Environmental files; Non-Communicable Diseases; Rare Diseases; Neurological conditions and Neurodegenerative diseases; Brain health; Mental /Women's / Maternal Health; Demographic Change.
Communication Activities
Event "Beyond the Stigma - how can Europe improve support for women and Post-Partum Mental Health", in partnership with Euractiv (December 2025)
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Biogen is a member of the following organisations: EFPIA – European Federation of Pharmaceutical Industries and Associations (https://efpia.eu/) Eucope – European Confederation of Pharmaceutical Entrepreneurs (https://www.eucope.org/) MFE – Medicines for Europe (https://www.medicinesforeurope.com/) IFPMA - International Federation of Pharmaceutical Manufacturers and Associations (https://www.ifpma.org/)
Organisation Members
Orphan Drug Expert Group (https://od-expertgroup.eu/about-us/) The Global CEO Initiative on Alzheimer's Disease (https://www.usagainstalzheimers.org/our-enterprise/CEOi)
Commissioner Meetings
No recorded meetings with EU commissioners.